About
Technology
Issues
FAQ
Links
Official Page
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.